Testing effectiveness (Phase 2)Study completedNCT04625985
What this trial is testing
Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2.
Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2
Laboratorios Silanes S.A. de C.V. 20